Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jai Radhakrishnan

Showing results (11-20 of 225) with videos related to

Pageof 23
Sort By:
Therapeutic Innovation & Regulatory Science|August 20, 2025
Master Protocols: A Promising Approach to Accelerate Drug Development in Rare Kidney DiseasesJulie Lin, Jai Radhakrishnan
Kidney International|May 3, 2026
Kidney International introduces new article type: Clinical Journey in Translational MedicineJai Radhakrishnan, Olivier Devuyst
Kidney Medicine|May 21, 2026
New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular DiseasesVladimir Mushailov, Jai Radhakrishnan
Kidney International|April 24, 2019
Capillary leak syndrome: a cytokine and catecholamine storm?Eric Siddall, Jai Radhakrishnan
Clinical Journal of the American Society of Nephrology : CJASN|October 27, 2022
The Role of Anti-B Cell Activating Factor Therapy for Treating Lupus NephritisBenjamin Wooden, Jai Radhakrishnan
Journal of the American Society of Nephrology : JASN|February 23, 2013
The treatment of minimal change disease in adultsJonathan Hogan, Jai Radhakrishnan
Kidney International|May 2, 2013
The authors replyJai Radhakrishnan, Daniel Cattran
Advances in Chronic Kidney Disease|August 30, 2014
The treatment of idiopathic focal segmental glomerulosclerosis in adultsJonathan Hogan, Jai Radhakrishnan
Kidney International Reports|November 17, 2017
<i>KI Reports</i> and World Kidney DayJai Radhakrishnan, Sumit Mohan
Clinical Journal of the American Society of Nephrology : CJASN|November 9, 2021
ANCA Vasculitis Treatment in the Dialysis Patient: Caution Needed!Elizabeth Hendren, Jai Radhakrishnan
Pageof 23

Showing results (11-20 of 225) with videos related to

Sort By:
Pageof 23
Therapeutic Innovation & Regulatory Science|August 20, 2025
Master Protocols: A Promising Approach to Accelerate Drug Development in Rare Kidney DiseasesJulie Lin, Jai Radhakrishnan
Kidney International|May 3, 2026
Kidney International introduces new article type: Clinical Journey in Translational MedicineJai Radhakrishnan, Olivier Devuyst
Kidney Medicine|May 21, 2026
New and Emerging Nonimmunosuppressive Drug Therapies for Primary Adult Glomerular DiseasesVladimir Mushailov, Jai Radhakrishnan
Kidney International|April 24, 2019
Capillary leak syndrome: a cytokine and catecholamine storm?Eric Siddall, Jai Radhakrishnan
Clinical Journal of the American Society of Nephrology : CJASN|October 27, 2022
The Role of Anti-B Cell Activating Factor Therapy for Treating Lupus NephritisBenjamin Wooden, Jai Radhakrishnan
Journal of the American Society of Nephrology : JASN|February 23, 2013
The treatment of minimal change disease in adultsJonathan Hogan, Jai Radhakrishnan
Kidney International|May 2, 2013
The authors replyJai Radhakrishnan, Daniel Cattran
Advances in Chronic Kidney Disease|August 30, 2014
The treatment of idiopathic focal segmental glomerulosclerosis in adultsJonathan Hogan, Jai Radhakrishnan
Kidney International Reports|November 17, 2017
<i>KI Reports</i> and World Kidney DayJai Radhakrishnan, Sumit Mohan
Clinical Journal of the American Society of Nephrology : CJASN|November 9, 2021
ANCA Vasculitis Treatment in the Dialysis Patient: Caution Needed!Elizabeth Hendren, Jai Radhakrishnan
Pageof 23